These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 897691)

  • 1. [Treatment of essential hyperlipidemia with procetofene. Apropos of 100 cases].
    Fromantin M; Gautier D; Bon R
    Sem Hop Ther; 1977; 53(5-6):311-6. PubMed ID: 897691
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid-lowering effects of procetofene.
    Afschrift M; Mets T; Verdonk G
    Lancet; 1977 Aug; 2(8032):311. PubMed ID: 69930
    [No Abstract]   [Full Text] [Related]  

  • 4. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 6. Antilipidemic drugs. Part 6: LF 178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia.
    Wülfert B; Majoie B; de Ceaurriz A
    Arzneimittelforschung; 1976; 26(5):906-9. PubMed ID: 183789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
    Rouffy J; Dreux C; Goussault Y; Dakkak R; Renson FJ
    Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary hyperlipoproteinaemias with a tetralin derivative (Su-13'437).
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    Atherosclerosis; 1973; 17(3):383-8. PubMed ID: 4577009
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of new lipotropic preparations in hyperlipemia].
    Miasnikov LA; Bavina MV; Lobova NM; Koropova GI
    Kardiologiia; 1971 Aug; 11(8):26-30. PubMed ID: 5160871
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antidyslipoproteinemic activity of ufibrate in patients with non-insulin-dependent diabetes mellitus].
    Dolzhenko AT; Nesterov OM; Petrenko IeV; Larina TF; Sahalovs'ka HIu
    Lik Sprava; 1997; (5):150-2. PubMed ID: 9491727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.
    Lenz PH; Fleischman AI
    Lipids; 1971 Nov; 6(11):783-6. PubMed ID: 5127473
    [No Abstract]   [Full Text] [Related]  

  • 12. [Elevation of glutamic-pyruvic transaminases under procetofene treatment of idiopathic hyperlipemia: incidence and significance in 443 treated cases].
    de Gennes JL; Truffert J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2398-9. PubMed ID: 673817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Procetophen--an alternative in the treatment of hypercholsterinemia?].
    Mordasini R; Grandjean EM; Nobile PC; Paumgartner G; Riva G
    Schweiz Med Wochenschr; 1979 Aug; 109(31):1140-3. PubMed ID: 472702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperlipidemia in the elderly].
    Kawano M
    Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of SU-13437 on serum lipids in hyperlipoproteinemic patients.
    Weiss P; Dujovne CA; Margolis S; Lasagna L; Bianchine JR
    Clin Pharmacol Ther; 1970; 11(1):90-6. PubMed ID: 4903694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of long-term treatment with fenofibrate on serum lipids and lipoproteins in patients with hypercholesterolemia and hypertriglyceridemia].
    Sznajderman M
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1633-7. PubMed ID: 3588382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.